SCWorx Corp.
0.2966-0.02 (-6.61%)
Oct 29, 4:00:00 PM EDT · NasdaqCM · WORX · USD
Key Stats
Market Cap
3.59MP/E (TTM)
-Basic EPS (TTM)
-1.15Dividend Yield
0%Recent Filings
8-K
Nasdaq bid price extension granted
SCWORX Corp. secured a 180-day Nasdaq extension on October 8, 2025, to lift its bid price below $1 per share, stemming from a prior April notice over 30 consecutive days ending April 9. Trading under WORX persists uninterrupted on the Nasdaq Capital Market until April 6, 2026. The company eyes a reverse stock split if needed. No assurance of appeal success if delisted.
8-K
Warrant inducement boosts capital
SCWorx Corp. inked warrant inducement deals on September 17, 2025, prompting holders to exercise existing warrants for 2,064,000 shares at $0.3496 each, netting $721,574 in gross proceeds for working capital. In exchange, the company issued new warrants for 4,128,000 shares at $0.31004, exercisable post-stockholder approval with a five-year term, but restricted further equity sales for 90 days after. Cash flows in now. Yet stockholder nod remains key to unlocking the new warrants.
10-Q
Q2 FY2025 results
SCWorx's Q2 revenue dipped 8.0% y/y to $682.6K while gross profit shrank 26.7% to $180.4K, reflecting expired customer contracts, yet operating expenses fell 14.4% to $473.9K on lower legal fees. The operating loss narrowed slightly to $293.5K, but net loss ballooned to $1.9M from $1.5M in other expenses, mainly amortization of debt discounts on new convertible notes. For the half-year, revenue slid 9.7% y/y to $1.4M with a $627.5K operating loss, widening to $2.4M net on $1.7M other costs; diluted EPS hit $(0.78) on 3.1M shares, consistent with calculations. Cash climbed to $340.2K on $1.3M financing inflows, leaving $51.8M convertible debt net of discounts (maturities 2025-2027 at 10%, secured by assets) and no revolver. No M&A or non-GAAP metrics disclosed in the 10-Q. Nasdaq compliance hangs by a thread.
10-Q
Q1 FY2025 results
SCWorx's Q1 revenue dipped 11% year-over-year to $720K from $812K, driven by expired customer contracts, while gross profit fell to $137K from $209K amid staffing cuts that trimmed costs. Operating expenses climbed 22% to $471K on higher legal fees and sales efforts, yielding an operating loss of $334K versus $178K last year; net loss widened to $476K, or $(0.25) per diluted share on 1.93M shares, with the gap to operating loss tied to $142K interest and $79K debt discount amortization. Cash swelled to $1.07M after $1.37M in financing from $2.66M convertible notes at 10% interest maturing 2025-2027, secured by assets, though operations burned $405K. No free cash flow disclosed in the 10-Q. Nasdaq bid price compliance hangs in the balance.
8-K
Nasdaq delisting warning issued
SCWorx Corp. received a Nasdaq delisting notice on April 10, 2025, for failing to maintain a $1 minimum bid price over 30 consecutive business days ending April 9. The exchange granted a 180-day compliance window through October 7 to hit $1 for ten straight days and avoid suspension. Yet the stock price lingers below par. Management eyes a reverse split if needed, as shareholders pre-approved.
IPO
Website
Employees
Sector
Industry
AMWL
American Well Corporation
5.32-0.02
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.39+0.00
DH
Definitive Healthcare Corp.
2.77-0.17
FORA
Forian Inc.
2.33-0.02
HCTI
Healthcare Triangle, Inc.
3.01+0.13
HSTM
HealthStream, Inc.
24.60-1.23
NRC
National Research Corporation
13.45+0.20
RMHI
Retrieve Medical Holdings Inc
1.30+0.00
SRXH
SRX Health Solutions, Inc.
0.34-0.03
SYRA
Syra Health Corp.
0.07+0.00